MARKSANS.NSE Marksans Pharma Ltd .

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Marksans Pharma Ltd . market cap is 76.65B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Marksans Pharma Ltd . 52 week high is 185.50 as of May 20, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Marksans Pharma Ltd . 52 week low is 70.55 as of May 20, 2024.

Marksans Pharma Ltd . stock price today is 166.80.

Marksans Pharma Ltd . stock price yesterday was 168.80.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Marksans Pharma Ltd .’s P/E ratio is 23.61.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Marksans Pharma Ltd . P/B ratio is 4.0869.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Marksans Pharma Ltd .'s EBITDA is 9.71.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Marksans Pharma Ltd . 50-day moving average is 156.98.

Marksans Pharma Ltd . has 1,400 employees.